Answer
Rapamune (sirolimus) is indicated to prevent organ rejection in adult kidney transplant recipients at low to moderate immunological risk.
Sources for this answer
- Rapamune 2 mg coated tabletsPfizer Limited · emc · SmPC §4.1 Therapeutic Indications · Version 54Document updated
Sources checked